Mamoru Yoshizawa

442 total citations
10 papers, 193 citations indexed

About

Mamoru Yoshizawa is a scholar working on Nephrology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mamoru Yoshizawa has authored 10 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Nephrology, 3 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mamoru Yoshizawa's work include Dialysis and Renal Disease Management (4 papers), Electrolyte and hormonal disorders (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Mamoru Yoshizawa is often cited by papers focused on Dialysis and Renal Disease Management (4 papers), Electrolyte and hormonal disorders (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Mamoru Yoshizawa collaborates with scholars based in Japan, Germany and United States. Mamoru Yoshizawa's co-authors include Atsuhiro Ichihara, Koichiro Homma, Yuki Kaneshiro, Tomoko Takemitsu, Tsuneo Takenaka, Takao Saruta, Tomohiro Furukawa, Matsuhiko Hayashi, Yoshihiko Kanno and Jürgen C. Frölich and has published in prestigious journals such as British Journal of Pharmacology, American Journal of Physiology-Endocrinology and Metabolism and American Journal of Kidney Diseases.

In The Last Decade

Mamoru Yoshizawa

9 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mamoru Yoshizawa Japan 7 89 70 35 28 26 10 193
Keisuke Yatsu Japan 11 51 0.6× 90 1.3× 36 1.0× 22 0.8× 15 0.6× 21 264
Dorota Polak‐Jonkisz Poland 10 69 0.8× 44 0.6× 19 0.5× 35 1.3× 22 0.8× 29 278
Ji Gao China 5 107 1.2× 37 0.5× 78 2.2× 77 2.8× 27 1.0× 6 260
A Okša Slovakia 8 187 2.1× 68 1.0× 89 2.5× 29 1.0× 74 2.8× 21 351
Giuseppe Ranieri Italy 10 34 0.4× 194 2.8× 52 1.5× 41 1.5× 12 0.5× 34 318
Tetsuya Fujikawa Japan 12 77 0.9× 118 1.7× 46 1.3× 57 2.0× 10 0.4× 36 315
Naïma Bellili-Muñoz France 10 52 0.6× 49 0.7× 68 1.9× 36 1.3× 27 1.0× 12 321
J. Green Israel 10 85 1.0× 56 0.8× 41 1.2× 34 1.2× 126 4.8× 10 339
Ingegjerd Sekse Norway 7 78 0.9× 77 1.1× 27 0.8× 19 0.7× 6 0.2× 11 188
Sanae Saka Japan 9 50 0.6× 47 0.7× 27 0.8× 27 1.0× 7 0.3× 26 173

Countries citing papers authored by Mamoru Yoshizawa

Since Specialization
Citations

This map shows the geographic impact of Mamoru Yoshizawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mamoru Yoshizawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mamoru Yoshizawa more than expected).

Fields of papers citing papers by Mamoru Yoshizawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mamoru Yoshizawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mamoru Yoshizawa. The network helps show where Mamoru Yoshizawa may publish in the future.

Co-authorship network of co-authors of Mamoru Yoshizawa

This figure shows the co-authorship network connecting the top 25 collaborators of Mamoru Yoshizawa. A scholar is included among the top collaborators of Mamoru Yoshizawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mamoru Yoshizawa. Mamoru Yoshizawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ookawara, Susumu, Kiyonori Ito, Tomoko Iida, et al.. (2025). Effect of intermittent infusion hemodiafiltration on cerebral and hepatic oxygenation. Renal Replacement Therapy. 11(1).
2.
3.
Watanabe, Sanae, et al.. (2006). The efficacy of pre-washed rice (Musenmai) on diet therapy for hemodialysis patients. Nihon Toseki Igakkai Zasshi. 39(6). 1187–1190. 2 indexed citations
4.
Ichihara, Atsuhiro, Matsuhiko Hayashi, Yuki Kaneshiro, et al.. (2005). Low Doses of Losartan and Trandolapril Improve Arterial Stiffness in Hemodialysis Patients. American Journal of Kidney Diseases. 45(5). 866–874. 76 indexed citations
5.
Hayashi, Masato, Y. Tsuchiya, Tomoyoshi Takenaka, et al.. (2004). Comparison of the effects of calcitriol and maxacalcitol on secondary hyperparathyroidism in patients on chronic haemodialysis: a randomized prospective multicentre trial. Nephrology Dialysis Transplantation. 19(8). 2067–2073. 28 indexed citations
6.
Okada, Hirokazu, Kenshi Moriwaki, Souichi Sugahara, et al.. (2000). Vitamin B6 supplementation can improve peripheral polyneuropathy in patients with chronic renal failure on high‐flux haemodialysis and human recombinant erythropoietin. Nephrology Dialysis Transplantation. 15(9). 1410–1413. 27 indexed citations
7.
Fauler, Joachim, et al.. (1991). Metabolism of cysteinyl leukotrienes by the isolated perfused rat kidney. Prostaglandins. 42(3). 239–249. 7 indexed citations
8.
Frölich, Jürgen C. & Mamoru Yoshizawa. (1987). Renal vascular effects of leukotriene C4in the isolated perfused kidney of the rat. British Journal of Pharmacology. 92(2). 311–318. 7 indexed citations
9.
Narumi, Shosaku, et al.. (1987). Effects of atrial natriuretic peptide on renal function and renin release in the isolated perfused rat kidney.. Japanese Heart Journal. 28(2). 221–227. 4 indexed citations
10.
Yoshizawa, Mamoru, et al.. (1984). Excretion and metabolism of dopa and dopamine by isolated perfused rat kidney. American Journal of Physiology-Endocrinology and Metabolism. 247(3). E285–E290. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026